Cancer patient: 'How can they put a price on my life?'
The NHS drugs watchdog in England has rejected a treatment that can extend the lives of some women with an advanced form of breast cancer because it's too expensive.
The high price of Kadcyla makes it "impossible" to recommend for widespread use in the health service, according to the National Institute for Health and Care Excellence.
Hayley Kalininis, 33, was diagnosed with breast cancer three years ago and been on Kadcyla for eighteen weeks.
This clip is originally from Breakfast 8th August 2014.
Duration:
This clip is from
Featured in...
![]()
News—5 Live In Short
The best current affairs interviews, insight and analysis from 蜜芽传媒 Radio 5 live.
More clips from 5 Live In Short
-
![]()
Theo Paphitis: 'Labour need to deliver economic growth'
Duration: 00:52
-
![]()
'We found over 200 of grandad's wartime letters to grandma'
Duration: 01:13
-
![]()
Lancaster Bomber pilot looks ahead to historic flypast
Duration: 01:20
-
![]()
Elite runner's top tips for marathon prep
Duration: 00:40
